RP
OFIX icon

Repertoire Partners’s Orthofix Medical OFIX Stock Holding History

Repertoire Partners’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,284
Closed -$289K – 72
2022
Q2 		$289K Buy
+12,284
New +$352K 0.1% 36

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Repertoire Partners's OFIX Position: Q3 2022 in Review

Repertoire Partners sold out of Orthofix Medical (OFIX) in Q3 2022, closing a stake of 12,284 shares — an estimated $289K sold.

Repertoire Partners first reported a position in OFIX in Q2 2022 and held it in 1 quarter. The position peaked at $289K in Q2 2022. 144 funds tracked by Wall St. Rank hold OFIX as of Q3 2022.

  • Repertoire Partners reported no remaining Orthofix Medical position as of Q3 2022 after selling out during the quarter.
  • Repertoire Partners sold 12,284 Orthofix Medical shares in Q3 2022, an estimated $289K.
  • Repertoire Partners first reported a position in Orthofix Medical in Q2 2022 and held it in 1 quarter.
  • Repertoire Partners's Orthofix Medical position peaked at $289K in Q2 2022.
  • 144 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2022.

Based on Repertoire Partners's 13F filing for Q3 2022, filed 14 Nov 2022.